- Joined
- Dec 10, 2019
- Messages
- 32
- Reaction score
- 93
When was the last time you treated a seminoma in the adjuvant setting?
Tough to tell what's adenopathy/bowel/vessel from one slice, but it looks like what I presume is a right common iliac node is getting short changed.
It's vessel. There's upstream venous congestion. Adenopathy is 7 cm AP/PA direction. There are some smaller nodes further south along the let iliac, but I had to stop somewhere. Resimming tomorrow after 12 Gy given shrinkage.Tough to tell what's adenopathy/bowel/vessel from one slice, but it looks like what I presume is a right common iliac node is getting short changed.
Thanks, Obama!To get an adjuvant, you'll have to more than likely have interested referrers for such on the urology and med onc side. Those interested referrers have not referred to me since the Obama administration.
"He who studies medicine without books sails an uncharted sea, but he who studies medicine without patients does not go to sea at all."I'm on track to have never seen it in residency.
I'll tell you what though, I certainly have sat through about 7 lectures and answered dozens of boards-related practice questions on the topic. I feel like I've seen one, does that count?
"Halstead! For the love of God, step away from the cocaine!""He who studies medicine without books sails an uncharted sea, but he who studies medicine without patients does not go to sea at all."
- William Osler
Lots of landlocked rad onc residents these days #sadfaceemoji
Let's not get crazy. Fellowships here would be silly and offensive. Practices and centers should simply credential rad oncs for seminoma treatment (AP/PA techniques and volumes are complex) via a thorough vetting process and that should suffice.About a decade for Stage I but I have treated 3 early PA recurrences with RT alone in the last five years. I am thinking of offering a seminoma fellowship.
Sounds like a high volume center of excellence.About a decade for Stage I but I have treated 3 early PA recurrences with RT alone in the last five years. I am thinking of offering a seminoma fellowship.
About a year ago. I try to avoid it when I can and the last couple I have done were all for the same reason: recent diagnosis preparing to deploy for active duty and unable to keep up with surveillance opting to treat before leaving. I also treated someone getting ready to serve an extended prison sentence who didn’t trust the government to take care of him. Otherwise I only treat for salvage and honestly that’s how it should be. These are super salvageable.When was the last time you treated a seminoma in the adjuvant setting?
That was my whole point. I am preparing for my clinical exam and learning the ‘dead art’ from the books and questions.I'm on track to have never seen it in residency.
I'll tell you what though, I certainly have sat through about 7 lectures and answered dozens of boards-related practice questions on the topic. I feel like I've seen one, does that count?
That was my whole point. I am preparing for my clinical exam and learning the ‘dead art’ from the books and questions.
NCCN mentions 36 Gy for larger lymph node...Not entirely. Adjuvant for stage 1 may be dead but it’s conceivable you could treat a stage 2 patient. The only difference is you boost the involved node to 30 Gy. These are a chip shot if you get them on your boards. It will go something like this: they have you stage it as stage 1. They ask you options expecting you to recommend surveillance. Then they tell you the patient is anxious and wants treatment. You tell them the can do carbo or RT and the patient will take RT. Then you have to tell them the dose (20 Gy) and describe the field (AP/PA). Use a clamshell. Boom, you passed.